Home LiteratureArticle Details
PMID: 18268281 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application.

Haematologica ·Vol. 93 ·No. 3 ·2008-03-00 ·Pages 339-46

Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M, Raviolo V, Lituania M, Kunkl A, Ferlazzo G, Bricarelli FD, Uccelli A, Frassoni F

Abstract

Mesenchymal stromal cells are multipotent cells considered to be of great promise for use in regenerative medicine. However, the cell dose may be a critical factor in many clinical conditions and the yield resulting from the ex vivo expansion of mesenchymal stromal cells derived from bone marrow may be insufficient. Thus, alternative sources of mesenchymal stromal cells need to be explored. In this study, mesenchymal stromal cells were successfully isolated from second trimester amniotic fluid and analyzed for chromosomal stability to validate their safety for potential utilization as a cell therapy product. Mesenchymal stromal cells were expanded up to the sixth passage starting from amniotic fluid using different culture conditions to optimize large-scale production. The highest number of mesenchymal stromal cells derived from amniotic fluid was reached at a low plating density; in these conditions the expansion of mesenchymal stromal cells from amniotic fluid was significantly greater than that of adult bone marrow-derived mesenchymal stromal cells. Mesenchymal stromal cells from amniotic fluid represent a relatively homogeneous population of immature cells with immunosuppressive properties and extensive proliferative potential. Despite their high proliferative capacity in culture, we did not observe any karyotypic abnormalities or transformation potential in vitro nor any tumorigenic effect in vivo. Fetal mesenchymal stromal cells can be extensively expanded from amniotic fluid, showing no karyotypic abnormalities or transformation potential in vitro and no tumorigenic effect in vivo. They represent a relatively homogeneous population of immature mesenchymal stromal cells with long telomeres, immunosuppressive properties and extensive proliferative potential. Our results indicate that amniotic fluid represents a rich source of mesenchymal stromal cells suitable for banking to be used when large amounts of cells are required.

MeSH Terms
Adipocytes/cytology Adult Age Factors Amniotic Fluid/cytology Animals Cell Culture Techniques/methods Cell Differentiation/drug effects Cell Transformation, Neoplastic Cells, Cultured/cytology,drug effects,transplantation Colony-Forming Units Assay Female Fetus/cytology Gestational Age Humans Karyotyping Lymphocyte Activation Mesenchymal Stem Cell Transplantation/adverse effects Mesenchymal Stem Cells/cytology Mice Mice, Inbred NOD Mice, SCID Multipotent Stem Cells/cytology,transplantation Osteoblasts/cytology Pregnancy Stromal Cells/cytology,transplantation Telomere/ultrastructure
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Sessarego Nadia
Centro Cellule Staminali e Terapia Cellulare, Ospedale San Martino, L.go R. Benzi 10, 16132 Genova Italy.
Parodi Alessia
Podestà Marina
Benvenuto Federica
Mogni Massimo
Raviolo Valentina
Lituania Mario
Kunkl Annalisa
Ferlazzo Guido
Bricarelli Franca Dagna
Uccelli Antonio
Frassoni Francesco
Article Info
Journal
Haematologica
Abbr.
Haematologica
ISSN
1592-8721
Published
2008-03-00
Epub
2008-00-11
Pages
339-46
Language
English
Region
Italy
NLM ID
0417435
Subset
IM
Grants
Telethon · GTF04003 · Italy
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]